Biomarkers Market, By Product Type (Biomarkers Test Kits, Biomarker Analyzer), By Application (Diagnostic Biomarkers, Monitoring Biomarkers, Drug discovery and development, Predictive biomarkers, Prognostic biomarkers), By Disease Indication (Cancer, Card

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	187 Pages	Coherent Market Insights	January, 2023	CMI17712931

Best Price Guarantee
Price	from $4,500
Length	187 Pages
Publisher	Coherent Market Insights
Published Date	January, 2023
SKU	CMI17712931

Biomarkers Market, By Product Type (Biomarkers Test Kits, Biomarker Analyzer), By Application (Diagnostic Biomarkers, Monitoring Biomarkers, Drug discovery and development, Predictive biomarkers, Prognostic biomarkers), By Disease Indication (Cancer, Cardiovascular disorders, Neurological Disorder, Infectious Disease, Others (Immunological Disorder, and Autoimmune Disorders among others )), By End User (Hospitals, Research laboratories, Diagnostic laboratories, Research and academic institute), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

A biomarker is a quantifiable sign of a biological condition or state. In order to investigate typical biological processes, pathogenic processes, or pharmacologic reactions to a therapeutic intervention, biomarkers are frequently examined and studied utilizing blood, urine, or soft tissues. Numerous scientific disciplines employ biomarkers. There are 2 types of biomarkers actively used in the market, they are Biomarker test Kits and Biomarker Analyzer. A relatively new set of clinical toolsets organized by clinical applications includes biomarkers utilized in the medical industry.

Market Dynamics

Increasing product launch by market players is expected to drive the market growth over the forecast period. For instance, on April 19, 2021, Amgen Inc., a global biotechnology company that uses science and innovation to translate novel concepts and medical discoveries into treatments for patients with life-threatening illnesses, announced the launch of the Biomarker Assist program, which aims to provide access to biomarker testing for patients with metastatic (stage IV) non-small cell lung cancer (NSCLC). A crucial initial step in placing patients on the appropriate course of treatment is biomarker testing at the time of diagnosis. Eligible patients may receive discounts on biomarker testing through Biomarker Assist.

Furthermore, on February 28, 2022, an initiative program was launched by the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium aims to find the most effective blood tests for assessing a protein that is crucial for the early detection of rare neurodegenerative illnesses. The "Neurofilament as a Fluid Biomarker of Neuro degeneration in Familial Front temporal Degeneration (FTD)" study will demonstrate that one or more blood tests for this protein, known as neurofilament, can be used to determine individuals at risk of Front temporal Degeneration (FTD) due to genetic and familial ties. This is a crucial first step in developing a trustworthy, affordable, and non-invasive method to more accurately predict Front temporal Degeneration (FTD). Also, those who are at threat can take part in clinical studies of novel specifics, eventually leading to the development of treatments.

Key features of the study:

This report provides an in-depth analysis of the global biomarkers market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global biomarkers market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies
Key companies covered as a part of this study include Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Acobiom, Apis Assay Technologies Ltd., Eagle Biosciences, Inc., Beckman Coulter, Inc., PerkinElmer Inc., Biopanda Reagents Ltd, Quanterix, Secure Diagnostics Pvt. Ltd., BioVision Inc., Merck KGaA, R&D Systems, Life Diagnostics, QuantaMatrix Inc., Nanjing Synthgene Medical Technology Co., Ltd, LifeSpan BioSciences, Inc., Wako USA, BioLegend, Inc., Abnova Corporation, and Abbexa
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global biomarkers market

Detailed Segmentation:

Global Biomarkers Market, By Product Type:
Biomarker Test Kits
Biomarker Analyzer
Global Biomarkers Market, By Application:
Diagnostic Biomarkers
Monitoring Biomarkers
Drug Discovery And Development
Predictive Biomarkers
Prognostic Biomarkers
Global Biomarkers Market, By Disease Indication
Cancer
Cardiovascular Disease
Neurological Disorder
Infectious disease
Others (Immunological Disorder, and Autoimmune Disorders among others )
Global Biomarkers Market, By End User:
Hospitals
Research Laboratories
Diagnostic Laboratories
Research and Academic Institute
Global Biomarkers market, By Region:
North America
By Country
U.S.
Canada
Latin America
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Country
GCC
Israel
Rest of Middle East
Africa
By Region/Country
South Africa
Central Africa
North Africa
Company Profiles
Agilent Technologies, Inc. *
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
F.Hoffmann-La Roche Ltd.
Acobiom
Apis Assay Technologies Ltd.
Eagle Biosciences, Inc.
Beckman Coulter, Inc.
PerkinElmer Inc.
Biopanda Reagents Ltd
Quanterix
Secure Diagnostics Pvt. Ltd.
BioVision Inc.
Merck KGaA
R&D Systems
Life Diagnostics
QuantaMatrix Inc.
Nanjing Synthgene Medical Technology Co. Ltd
LifeSpan BioSciences Inc
Wako USA,
BioLegend, Inc
Abnova Corporation
Abbexa

“*” marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Product Type; Market Snapshot, By Application; Market Snapshot, By Disease Indication; Market Snapshot, By End User; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Opportunity; Impact Analysis; Key Developments; Industry Trends; Regulatory Scenario; Recent Product Approval/Launches; PEST Analysis; Porter’s Analysis
4. Global Biomarkers Market– Impact of Coronavirus (COVID-19) Pandemic: Impact on Demand; Impact on Healthcare; Epidemiology
5. Global Biomarkers Market, By Type, 2017 – 2030, (US$ Bn): Introduction; Market Share Analysis, 2022 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends; Biomarker Test; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Bn); Biomarker Analyzers; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
6. Global Biomarkers Market, By Application, 2017 – 2030, (US$ Bn): Introduction; Market Share Analysis, 2022 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends; Diagnostic Biomarkers; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Bn); Monitoring Biomarkers; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn); Drug discovery and development; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn); Predictive Biomarkers; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn); Prognostic Biomarkers; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
7. Global Biomarkers Market, By Disease Indication, 2017 – 2030, (US$ Bn): Introduction; Market Share Analysis, 2022 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends; Cancer; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Bn); Cardiovascular Disease; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn); Neurological Disorder; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Bn); Infectious disease; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn); Others (Immunological Disorder, and Autoimmune Disorders among others ); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
8. Global Biomarkers Market, End User, 2017 – 2030 (US$ Billion): Introduction; Market Share Analysis, By Region, 2022 and 2030(%); Y-o-Y Growth Analysis, For Regions, 2017 - 2030; Regional Trends; Hospitals; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017– 2030, (US$ Bn); Research Laboratories; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn); Diagnostic Laboratories; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017– 2030, (US$ Bn); Research and Academic Institute; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
9. Global Biomarker Market, By Region, 2017 – 2030 (US$ Billion): Introduction; Market Share Analysis, By Region, 2022 and 2030(%); Y-o-Y Growth Analysis, For Regions, 2017 - 2030; Regional Trends; North America; Market Size and Forecast, By Type, 2017 – 2030 (US$ Bn); Market Size and Forecast, By Application, 2017 – 2030 (US$ Bn); Market Size and Forecast, By Disease Indication, 2017 – 2030 (US$ Bn); Market Size and Forecast, By End User, 2017 – 2030 (US$ Bn); U.S.; Canada; Latin America; Market Size and Forecast, By Type, 2017 – 2030 (US$ Bn); Market Size and Forecast, By Application, 2017 – 2030 (US$ Bn); Market Size and Forecast, By Disease Indication, 2017 – 2030 (US$ Bn); Market Size and Forecast, By End User, 2017 – 2030 (US$ Bn); Brazil; Mexico; Argentina; Rest of Latin America; Europe; Market Size and Forecast, By Type, 2017 – 2030 (US$ Bn); Market Size and Forecast, By Application, 2017 – 2030 (US$ Bn); Market Size and Forecast, By Disease Indication, 2017 – 2030 (US$ Bn); Market Size and Forecast, By End User, 2017 – 2030 (US$ Bn); Germany; U.K.; France; Italy; Spain; Russia; Rest of Europe; Asia Pacific; Market Size and Forecast, By Type, 2017 – 2030 (US$ Bn); Market Size and Forecast, By Application, 2017 – 2030 (US$ Bn); Market Size and Forecast, By Disease Indication, 2017 – 2030 (US$ Bn); Market Size and Forecast, By End User, 2017 – 2030 (US$ Bn); China; India; Japan; Australia; South Korea; ASEAN; Rest of Asia Pacific; Middle East; Market Size and Forecast, By Type, 2017 – 2030 (US$ Bn); Market Size and Forecast, By Application, 2017 – 2030 (US$ Bn); Market Size and Forecast, By Disease Indication, 2017 – 2030 (US$ Bn); Market Size and Forecast, By End User, 2017 – 2030 (US$ Bn); GCC; Israel; Rest of Middle East; Africa; Market Size and Forecast, By Type, 2017 – 2030 (US$ Bn); Market Size and Forecast, By Application, 2017 – 2030 (US$ Bn); Market Size and Forecast, By Disease Indication, 2017 – 2030 (US$ Bn); Market Size and Forecast, By End User, 2017 – 2030 (US$ Bn); South Africa; Central Africa; North Africa; 10. Competitive Landscape; Heat Map Analysis; Market Share Analysis; Agilent Technologies, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; F.Hoffmann-La Roche Ltd.; Acobiom; Apis Assay Technologies Ltd.; Eagle Biosciences, Inc.; Beckman Coulter, Inc.; PerkinElmer Inc.; Biopanda Reagents Ltd; Quanterix; Secure Diagnostics Pvt. Ltd.; BioVision Inc.; Merck KGaA; R&D Systems; Life Diagnostics; QuantaMatrix Inc.; Nanjing Synthgene Medical Technology Co., Ltd; LifeSpan BioSciences, Inc.; WakUSA; BioLegend, Inc.; Abnova Corporation; Abbexa; Analyst Views; 11. Section; Research Methodology; About Us; *Browse 40 market data tables and 48 figures on “Global Biomarkers Market” - forecast t2030